enGene Therapeutics Inc.
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Results 2026-05-12
enGene Therapeutics Inc. Reports Additional Interim Results from Pivotal Phase 2 LEGEND Trial of Detalimogene Voraplasmid in High-Risk, BCG-Unresponsive NMIBC Patients
Material change report - English.pdf
Results 2026-05-07
enGene Announces Updated Interim Results From LEGEND Pivotal Cohort
News release - English.pdf
Results 2026-05-07
enGene Announces Updated Interim Results From LEGEND Pivotal Cohort
News release - English.pdf
Ownership 2026-04-09
Other securityholders documents - English.pdf
Ownership 2026-04-09
Other securityholders documents - English.pdf
Results 2026-03-09 Financials
Interim MD&A - English.pdf
Results 2026-03-09 Financials
Interim financial statements/report – English.pdf
Transactions 2026-03-09
Other material contracts - English.pdf
Results 2026-03-09
enGene Reports First Quarter 2026 Financial Results and Provides Business Update
News release - English.pdf
Results 2026-03-09
enGene Reports First Quarter 2026 Financial Results and Provides Business Update
News release - English.pdf
Results 2026-02-19 Financials
Annual report (amended) - English.pdf
News 2026-01-29
Report of exempt distribution (45-106F1) (amended).pdf
News 2026-01-26
Report of exempt distribution (45-106F1).pdf
Transactions 2026-01-21 Financing
enGene Holdings Inc. entered into an amendment to an amended and restated loan and security agreement for up to US$125 million
Material change report - English.pdf
Transactions 2026-01-21
Material contracts - Credit agreements.pdf
Transactions 2026-01-20 Financing
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.
News release - English.pdf
Results 2025-12-22 Financials
Annual report - English.pdf
Results 2025-12-22 Financials
Annual MD&A - English.pdf
Results 2025-12-22 Financials
Audited annual financial statements – English.pdf
Results 2025-12-22
enGene Reports Full Year 2025 Financial Results and Provides Business Update
News release - English.pdf
News 2025-12-02
News release - English.pdf
News 2025-12-02
enGene's Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness
News release - English.pdf
Transactions 2025-11-18 Financing
enGene Holdings Inc. Announces Pricing of Underwritten Public Offering
Material change report - English.pdf
Transactions 2025-11-14
Other material contracts - English.pdf
News 2025-11-13
News release - English.pdf
News 2025-11-13
News release - English.pdf
News 2025-11-12
News release - English.pdf
News 2025-11-12
Other.pdf
News 2025-11-12
Material change report - English.pdf
News 2025-11-11
News release - English.pdf
News 2025-11-11
News release - English.pdf
News 2025-11-10
News release - English.pdf
News 2025-11-06
News release - English.pdf
News 2025-11-04
News release - English.pdf
News 2025-10-01
News release - English.pdf
News 2025-09-30
News release - English.pdf
Results 2025-09-11 Financials
Interim MD&A - English.pdf
Results 2025-09-11 Financials
Interim financial statements/report – English.pdf
Results 2025-09-11 Financials
Interim financial statements/report – English.pdf
News 2025-09-11
News release - English.pdf
News 2025-09-03
News release - English.pdf
News 2025-08-27
News release - English.pdf
News 2025-08-04
News release - English.pdf
News 2025-08-04
News release - English.pdf
News 2025-07-08
Other.pdf
News 2025-07-08
News release - English.pdf
News 2025-06-25
News release - English.pdf
News 2025-06-17
News release - English.pdf
Results 2025-06-12 Financials
Interim MD&A - English.pdf
Results 2025-06-12 Financials
Interim financial statements/report – English.pdf
Results 2025-06-12 Financials
Interim financial statements/report – English.pdf
News 2025-06-12
News release - English.pdf
News 2025-06-09
Material change report - English.pdf
News 2025-06-04
News release - English.pdf